ATOSSA THERAPEUTICS, INC. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
ATOSSA THERAPEUTICS, INC. (ATOS) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2026-03-25
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-06-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2025-03-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2025 was $0.00.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2024 was -$7.00K.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2023 was $0.00.
- ATOSSA THERAPEUTICS, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was -$3.00K.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month as first filed | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | -$4.00K derived: sum of 4 quarters · filed 2026-03-25 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | -$4.00K derived: sum of 3 quarters · filed 2026-03-25 | -$3.00K derived: sum of 4 quarters · filed 2026-03-25 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | -$4.00K derived: sum of 2 quarters · filed 2026-03-25 | -$3.00K derived: sum of 3 quarters · filed 2026-03-25 | -$5.00K derived: sum of 4 quarters · filed 2026-03-25 | ||
| 2024-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.00K derived: sum of 2 quarters · filed 2026-03-25 | -$5.00K derived: sum of 3 quarters · filed 2026-03-25 | -$7.00K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2025-11-12 | -$3.00K 10-Q · filed 2025-11-12 | -$3.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$4.00K 10-Q · filed 2025-08-12 | -$4.00K derived: sum of 3 quarters · filed 2025-08-12 | -$4.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$2.00K 10-Q · filed 2025-05-13 | -$2.00K derived: sum of 2 quarters · filed 2025-05-13 | -$2.00K derived: sum of 3 quarters · filed 2025-05-13 | -$2.00K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $0.00 derived: sum of 2 quarters · filed 2025-03-25 | $0.00 derived: sum of 3 quarters · filed 2025-03-25 | $0.00 10-K · filed 2025-03-25 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2024-08-12 | -$2.00K derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $0.00 derived: sum of 2 quarters · filed 2024-05-13 | -$2.00K derived: sum of 3 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$2.00K derived: sum of 2 quarters · filed 2024-04-01 | -$3.00K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$3.00K 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$1.00K 10-Q · filed 2023-08-14 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | |||||
| 2020-12-31 | -$27.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$29.77K derived: sum of 2 quarters · filed 2022-02-28 | -$32.00K 10-K · filed 2022-02-28 | -$31.73K 10-K · filed 2021-03-31 | ||
| 2020-09-30 | -$1.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.15K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | -$2.23K 10-Q · filed 2021-08-13 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | -$5.81K 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$5.81K 10-Q · filed 2020-11-13 | ||||
| 2019-06-30 | -$5.81K 10-Q · filed 2020-08-13 | |||||
| 2017-12-31 | -$35.39K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $0.00 derived: sum of 2 quarters · filed 2019-03-28 | $0.00 derived: sum of 3 quarters · filed 2019-03-28 | -$17.70K 10-K · filed 2019-03-28 | ||
| 2017-09-30 | $35.39K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | $35.39K derived: sum of 2 quarters · filed 2018-11-14 | $17.70K 10-Q · filed 2018-11-14 | -$17.70K 10-Q · filed 2017-11-13 | $17.70K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-11-13 | -$17.70K 10-Q/A · filed 2018-11-13 | -$17.70K derived: sum of 3 quarters · filed 2018-11-13 | -$17.70K derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2017-03-31 | -$17.70K 10-Q · filed 2018-05-14 | -$17.70K derived: sum of 2 quarters · filed 2018-05-14 | -$17.70K derived: sum of 3 quarters · filed 2018-05-14 | -$17.70K derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-08 | -$163.33K 10-K · filed 2018-03-08 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | -$163.33K 10-Q · filed 2017-11-13 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$163.33K 10-Q · filed 2017-08-14 | ||||
| 2016-03-31 | -$163.33K 10-Q · filed 2017-05-11 | |||||
| 2015-09-30 | $81.33K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | $74.80K 10-Q/A · filed 2017-03-21 | ||||
| 2015-06-30 | -$6.53K 10-Q/A · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |